1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Gilquin, B. Roumestand, C. Zinn-Justin, S. Menez, A. Toma, F. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biopolymers BIPMAA 0161 0006-3525 33 1659 1675 10.1002/bip.360331104 8241426 Refined three-dimensional solution structure of a snake cardiotoxin: analysis of the side-chain organization suggests the existence of a possible phospholipid binding site. 1993 To be Published 0353 Proton NMR Studies of the Structural and Dynamical Effects of Chemical Modification of Single Aromatic Side Chain in a Snake Cardiotoxin: Relation with the Structure of the Putative Binding Site and the Cytolitic Activity of the Toxin 10.2210/pdb1cxn/pdb pdb_00001cxn 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 6838.462 CARDIOTOXIN GAMMA 1 man polymer no no LKCNQLIPPFWKTCPKGKNLCYKMTMRAAPMVPVKRGCIDVCPKSSLLIKYMCCNTDKCN LKCNQLIPPFWKTCPKGKNLCYKMTMRAAPMVPVKRGCIDVCPKSSLLIKYMCCNTDKCN A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n spitting cobra Naja sample 8654 Naja nigricollis database_2 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1994-12-20 1 1 2008-03-24 1 2 2011-07-13 1 3 2022-02-16 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site Y BNL 1994-07-08 REL 1 BRUNGER refinement X-PLOR LEU 1 n 1 LEU 1 A LYS 2 n 2 LYS 2 A CYS 3 n 3 CYS 3 A ASN 4 n 4 ASN 4 A GLN 5 n 5 GLN 5 A LEU 6 n 6 LEU 6 A ILE 7 n 7 ILE 7 A PRO 8 n 8 PRO 8 A PRO 9 n 9 PRO 9 A PHE 10 n 10 PHE 10 A TRP 11 n 11 TRP 11 A LYS 12 n 12 LYS 12 A THR 13 n 13 THR 13 A CYS 14 n 14 CYS 14 A PRO 15 n 15 PRO 15 A LYS 16 n 16 LYS 16 A GLY 17 n 17 GLY 17 A LYS 18 n 18 LYS 18 A ASN 19 n 19 ASN 19 A LEU 20 n 20 LEU 20 A CYS 21 n 21 CYS 21 A TYR 22 n 22 TYR 22 A LYS 23 n 23 LYS 23 A MET 24 n 24 MET 24 A THR 25 n 25 THR 25 A MET 26 n 26 MET 26 A ARG 27 n 27 ARG 27 A ALA 28 n 28 ALA 28 A ALA 29 n 29 ALA 29 A PRO 30 n 30 PRO 30 A MET 31 n 31 MET 31 A VAL 32 n 32 VAL 32 A PRO 33 n 33 PRO 33 A VAL 34 n 34 VAL 34 A LYS 35 n 35 LYS 35 A ARG 36 n 36 ARG 36 A GLY 37 n 37 GLY 37 A CYS 38 n 38 CYS 38 A ILE 39 n 39 ILE 39 A ASP 40 n 40 ASP 40 A VAL 41 n 41 VAL 41 A CYS 42 n 42 CYS 42 A PRO 43 n 43 PRO 43 A LYS 44 n 44 LYS 44 A SER 45 n 45 SER 45 A SER 46 n 46 SER 46 A LEU 47 n 47 LEU 47 A LEU 48 n 48 LEU 48 A ILE 49 n 49 ILE 49 A LYS 50 n 50 LYS 50 A TYR 51 n 51 TYR 51 A MET 52 n 52 MET 52 A CYS 53 n 53 CYS 53 A CYS 54 n 54 CYS 54 A ASN 55 n 55 ASN 55 A THR 56 n 56 THR 56 A ASP 57 n 57 ASP 57 A LYS 58 n 58 LYS 58 A CYS 59 n 59 CYS 59 A ASN 60 n 60 ASN 60 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N CYS 3 A N CYS 3 A O LYS 12 A O LYS 12 A O ILE 39 A O ILE 39 A N LEU 20 A N LEU 20 A O THR 25 A O THR 25 A N LYS 50 A N LYS 50 1 -5.33 0.70 120.80 115.47 A A A CB CG CD2 PHE PHE PHE 10 10 10 N 1 -7.24 1.00 110.10 102.86 A A A CG CD1 NE1 TRP TRP TRP 11 11 11 N 1 8.08 0.90 109.00 117.08 A A A CD1 NE1 CE2 TRP TRP TRP 11 11 11 N 1 9.44 1.10 130.40 139.84 A A A NE1 CE2 CZ2 TRP TRP TRP 11 11 11 N 1 -6.30 1.00 107.30 101.00 A A A NE1 CE2 CD2 TRP TRP TRP 11 11 11 N 1 A A CA CB LYS LYS 18 18 -0.146 0.022 1.535 1.389 N 1 A GLN 5 -89.51 -118.47 1 A LEU 6 -64.35 -113.16 1 A PRO 9 -51.46 75.67 1 A PRO 30 -61.20 -70.54 1 A MET 31 -155.75 65.63 1 A PRO 33 -66.61 96.23 1 A VAL 34 -90.88 -70.78 1 A ILE 39 -134.62 -157.76 1 A ASP 40 -121.92 -62.63 1 A LYS 58 67.60 -24.75 model building X-PLOR refinement X-PLOR phasing X-PLOR REFINED THREE-DIMENSIONAL SOLUTION STRUCTURE OF A SNAKE CARDIOTOXIN: ANALYSIS OF THE SIDE-CHAIN ORGANISATION SUGGESTS THE EXISTENCE OF A POSSIBLE PHOSPHOLIPID BINDING SITE 1 Y N disulf 2.015 A CYS 3 A SG CYS 3 1_555 A CYS 21 A SG CYS 21 1_555 disulf 2.021 A CYS 14 A SG CYS 14 1_555 A CYS 38 A SG CYS 38 1_555 disulf 2.015 A CYS 42 A SG CYS 42 1_555 A CYS 53 A SG CYS 53 1_555 disulf 2.017 A CYS 54 A SG CYS 54 1_555 A CYS 59 A SG CYS 59 1_555 CYTOTOXIN CYTOTOXIN CX1_NAJPA UNP 1 1 P01468 LKCNQLIPPFWKTCPKGKNLCYKMTMRAAPMVPVKRGCIDVCPKSSLLIKYMCCNTDKCN 1 60 1CXN 1 60 P01468 A 1 1 60 2 3 anti-parallel anti-parallel anti-parallel A LYS 2 A LYS 2 A ASN 4 A ASN 4 A TRP 11 A TRP 11 A THR 13 A THR 13 A VAL 32 A VAL 32 A ILE 39 A ILE 39 A LEU 20 A LEU 20 A MET 26 A MET 26 A ILE 49 A ILE 49 A CYS 54 A CYS 54 1 P 1